Lagare, Rozalyn P.
HRN: 24-39-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2024
CO-AMOXICLAV 625MG (TAB)
02/08/2024
02/14/2024
PO
1 Tab
Bid
Thinly Msaf 2nd Degree Rmle And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes